High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)

Table 1 Univariate analyses for the determinants of plaque progression

Factor	β	95% CI	p Value
BMI	0.766	0.017, 1.514	0.045
Use of ACE inhibitors	−6.655	−12.604, –0.706	0.0286
Use of sulfonylureas	6.672	0.100, 13.244	0.0467
HbA1c	2.941	0.452, 5.429	0.0209
Evaluated plaque length	−0.997	−1.698, –0.296	0.0057
Plaque volume	−0.112	−0.174, –0.049	0.0006
Vessel volume	−0.047	−0.080, –0.013	0.0067
Plaque area	−0.918	−1.598, –0.238	0.0086

ISSN: 1475-2840